Osorio et al. [62] reported that phloridzin treatment reduced hyperglycemia, normalized hypertension and inhibited SGLT2 activity but did not modify SGLT2 expression in brush border membrane vesicles. The gene discussed is SLC5A2; the disease is Hypertension.